SFTPA1 and lung carcinoma: Pathophysiology and diagnostic approaches—Several aspects were explored: Accuracy of clinical diagnostic criteria for patients with vascular Ehlers-Danlos syndrome in a tertiary reference center for the RaDiCo-SEDVasc cohort [17]; In the RaDiCo-PID cohort, functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer [18]; Pulmonary fibrosis in children [19]; Diagnosis approaches of chronic interstitial lung diseases in children: [20–22]; or genetic causes and clinical management of pediatric interstitial lung diseases [23].